Carcinoma: all 6,715 studies
Page 35 of 68. Open to participants first (1,140), then studies with results posted, then the rest; newest registration first within each.
- Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT04479527Phase 2
- Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II TrialStatus unknownNCT04475159Phase 2
- Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal CarcinomaStatus unknownNCT04472403
- RFA Using Gradual RF Energy Delivery Mode With Octopus ElectrodesStatus unknownNCT04471272Not applicable
- Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma SubtypeCompletedNCT04470726Phase 1/2
- KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic CarcinomaTerminatedNCT04469725Phase 2
- A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCCWithdrawnNCT04465734Phase 3
- Prospective Translational Study Investigating Possible Molecular prEdictors of Resistance to First-Line pazopanIbCompletedNCT04462445Phase 2
- A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain MetastasesWithdrawnNCT04460729Phase 2
- Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit StudyCompletedNCT04456140Phase 1
- A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver FunctionStatus unknownNCT04454762Phase 2
- A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid TumorsCompletedNCT04452214Phase 1
- LiverMultiScan Analysis of MRI Scans in HCCCompletedNCT04451603
- Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS StudyCompletedNCT04449679Not applicable
- Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT04447612Phase 2
- A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular CarcinomaCompletedNCT04444167Phase 1/2
- Lenvatinib in Combination With Camrelizumab as First-Line Therapy in Patients With Advanced HCCStatus unknownNCT04443309Phase 1/2
- Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical CarcinomaStatus unknownNCT04443296Phase 1
- To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.Status unknownNCT04443049Not applicable
- Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ CarcinomaStatus unknownNCT04443036Not applicable
- A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced MalignanciesCompletedNCT04440943Phase 1
- Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell CarcinomaStatus unknownNCT04440917Phase 2
- Surveillance of Peripheral Blood of Lymphocyte and Immunocyte in Neoadjuvant Therapy Patients With Esophageal Squamous Cell Carcinoma (pLINE)Status unknownNCT04440332
- A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)TerminatedNCT04438083Phase 1
- A Study of SBRT for Squamous Cell Carcinoma of the Head and NeckStatus unknownNCT04435938Phase 2
- Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell CarcinomaCompletedNCT04435197Phase 2
- All-trans Retinoic Acid (ATRA) in the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and NeckStatus unknownNCT04433169Phase 2
- A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-upStatus unknownNCT04432909
- PD-1 Monoclonal Antibody in Pre-treated Lymphoepithelioma-like CarcinomaStatus unknownNCT04430166Not applicable
- Organochlorine Concentration in Adipose Tissue and Pancreatic AdenocarcinomaCompletedNCT04429490Not applicable
- Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected PrimaryTerminatedNCT04429321Phase 1
- Evaluation of Bintrafusp Alfa in Operable and Untreated Head and Neck Squamous Cell CarcinomaTerminatedNCT04428047Phase 2
- Pembrolizumab and LENvatinib in Participants With Hepatocellular Carcinoma (HCC) Before Liver TransplantStatus unknownNCT04425226Not applicable
- The Microbiome of Oesophageal Squamous Cell CarcinomaStatus unknownNCT04425122
- Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell CarcinomaStatus unknownNCT04424472Not applicable
- Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast CancerWithdrawnNCT04418219Phase 1/2
- Prognostic Utility of the Imaging and Biological Signatures in Nasopharyngeal CarcinomaCompletedNCT04417985Not applicable
- TACE Combined With PD-1 Knockout Engineered T Cell in Advanced Hepatocellular Carcinoma.Status unknownNCT04417764Phase 1
- Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway InhibitorCompletedNCT04416516Phase 2
- Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver TransplantationCompletedNCT04415567
- Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I TrialCompletedNCT04413214Phase 1
- Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFPCompletedNCT04412161
- Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid DiseasesStatus unknownNCT04411290
- Imvamune Vaccine for the Treatment of Non-melanoma Skin CancerTerminatedNCT04410874Phase 1/2
- Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma.Status unknownNCT04405622Phase 2
- The Incidence of Pulmonary Embolism During NephrectomyCompletedNCT04402749
- Efficacy and Safety of IBI310 Combined with Sintilimab in Patients with Advanced Hepatocellular CarcinomaCompletedNCT04401813Phase 1
- Phase II Study for Combination of Camrelizumab and SBRT in the First-line Treatment for R/M HNSCCStatus unknownNCT04399785Phase 2
- Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal CarcinomaStatus unknownNCT04398056Phase 2
- Biweekly TPF Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of Head and NeckCompletedNCT04397341Phase 2
- Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPCCompletedNCT04396886Phase 2
- Post-treatment Ultrasensitive Positron Emission Tomography in Nasopharyngeal Carcinoma PatientsStatus unknownNCT04394091
- uEXPLORER Total-body PET/CT in Nasopharyngeal CarcinomaCompletedNCT04394065
- A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative ResectionStatus unknownNCT04392700Phase 3
- Combination PET With 18F-fluorodeoxyglucose (18F-FDG) and 18 F-choline in Patient With HCCCompletedNCT04391348Not applicable
- Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell CarcinomaStatus unknownNCT04390958Phase 2
- Pembrolizumab Plus Paclitaxel, Cisplatin Followed by Surgery for Locally Advanced ESCC (KEYSTONE-001)Status unknownNCT04389177Phase 2
- SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTTStatus unknownNCT04387695Phase 3
- Myeloid-derived Suppressor Cells (MDSCs) in OSCC PatientsStatus unknownNCT04387682Not applicable
- Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell CarcinomaActive, not recruitingNCT04387500Phase 2
- To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPCCompletedNCT04387266
- Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular CarcinomaStatus unknownNCT04386772Not applicable
- Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell CarcinomaStatus unknownNCT04385654Phase 2
- A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma PatientsStatus unknownNCT04383067Phase 2
- Percutaneous Endoscopic Gastrostomy Before Definitive Concurrent Chemoradiation Therapy for Esophageal Squamous Cell CarcinomaCompletedNCT04380480Phase 2
- Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)Active, not recruitingNCT04379596Phase 2
- Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)CompletedNCT04373265Phase 1
- AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular CarcinomaStatus unknownNCT04368182Phase 1
- Lenvatinib Combined Toripalimab in Advanced Hepatocellular CarcinomaStatus unknownNCT04368078Phase 2
- A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell CarcinomaStatus unknownNCT04367909Phase 2
- A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR ExpressionsStatus unknownNCT04363242Phase 1
- Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT04361409Phase 1
- Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different LocationsCompletedNCT04357873Phase 2
- Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint InhibitorsCompletedNCT04353765
- Intraoperative ICG Fluorescence Imaging for Peritoneal Carcinomatosis DetectionStatus unknownNCT04352894Not applicable
- T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast CancerWithdrawnNCT04351230Phase 2
- Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal CarcinomaCompletedNCT04350190Phase 2
- Renal Cell Carcinoma and Stage IV Inferior Vena Cava Thrombus: Resection Without ThoracotomyCompletedNCT04350047
- Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin MalignanciesActive, not recruitingNCT04349436Phase 1/2
- An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"WithdrawnNCT04349111Not applicable
- Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid TumorsTerminatedNCT04348916Phase 1
- A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)Active, not recruitingNCT04344158Phase 3
- Investigating Marrow Infiltrating Lymphocytes in Renal Cell CarcinomaTerminatedNCT04341740Not applicable
- Link of Interest and Training ModelCompletedNCT04341337
- Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0?Status unknownNCT04336696Not applicable
- A Study to Evaluate the Safety and Efficacy of PLM60 in Advanced HCCStatus unknownNCT04331743Phase 1
- A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic CarcinomaCompletedNCT04321330Phase 2
- Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal CarcinomaStatus unknownNCT04319471Phase 2
- "Cocktail" Therapy for Hepatitis B Related Hepatocellular CarcinomaStatus unknownNCT04317248Phase 2
- Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial CarcinomaCompletedNCT04314245
- GEN2 Directed Cancer Immunotherapy TrialCompletedNCT04313868Phase 1
- Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma VirusCompletedNCT04312737
- Clinical Trial of Sintilimab Combined With Gemcitabine/Carboplatin Regimen in the Treatment of Advanced Primary Pulmonary Lymphoepithelioma-like CarcinomaStatus unknownNCT04312204Phase 2
- Combination of Regorafenib and Nivolumab in Unresectable Hepatocellular CarcinomaCompletedNCT04310709Phase 2
- PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver CancerCompletedNCT04310540Early Phase 1
- Utility of Squamous Cell Carcinoma Antigen (SCCA) in PsoriasisCompletedNCT04308616
- Lactate and Complications in Cytoreduction Surgery for Peritoneal CarcinomatosisCompletedNCT04307654
- An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid TumorsActive, not recruitingNCT04305795Phase 1/2
- The Association of hsCRP and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal CarcinomaStatus unknownNCT04303975
- The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular CarcinomaCompletedNCT04303286